Skip to main navigation Skip to search Skip to main content

Prevalence and Consequences of APC Mosaicism in Patients With Colorectal Adenomas

  • Diantha Terlouw
  • , Manon Suerink
  • , Yentl Buitelaar
  • , Monique E. van Leerdam
  • , Frederik J. Hes
  • , Demi van Egmond
  • , Dina Ruano
  • , Anja Wagner
  • , Floris H. Groenendijk
  • , Isabelle C. Meijssen
  • , Eline Overwater
  • , Sanne W. Bajwa-ten Broeke
  • , Arjen R. Mensenkamp
  • , Iris D. Nagtegaal
  • , Carli M. Tops
  • , Alexandra M.J. Langers
  • , Tom van Wezel
  • , Hans Morreau
  • , Maartje Nielsen*
  • *Corresponding author for this work
  • Leiden University
  • Leiden University Medical Centre
  • Vrije Universiteit Brussel
  • University Medical Centre Groningen
  • Radboud University Medical Center

Research output: Contribution to journal › Article › Academic › peer-review

7 Citations (Scopus)
32 Downloads (Pure)

Abstract

Background & Aims:

A substantial proportion of patients with adenomatous polyposis have no germline pathogenic variant in APC. The aim of this study was to determine the prevalence of APC mosaicism in these patients with unexplained polyposis and to draft guidelines for APC mosaicism testing and surveillance. 

Methods: 

APC mosaicism was analyzed by targeted next-generation sequencing in 541 patients with a broad spectrum of polyposis phenotypes. 

Results:

The rate of APC mosaicism was 9.4%. This rate was 14.3% (46 of 322) in patients who met the scope of national hereditary polyposis testing guidelines (≥10 adenomas before the age of 60 or with ≥20 adenomas before the age of 70). In patients who did not meet the scope of national guidelines, the detection rate was 2.3% (5 of 219). In patients with ≥20 adenomas before the age of 60 or ≥30 adenomas before the age of 70, the detection rate was ≥10%. Of 34 mosaic patients who underwent an esophagogastroduodenoscopy, 26% were diagnosed with gastroduodenal polyps. In 1 of the 2 patients tested, the mosaic variant was detected in semen, but none of the children tested in this cohort inherited the mosaic variant. 

Conclusions: 

We recommend APC mosaicism testing at least in patients negative for germline pathogenic variants with (1) ≥20 adenomas before the age of 60 or (2) ≥30 adenomas before the age of 70. Regular colonoscopy and at least 1 gastroduodenoscopy should be offered to APC mosaic patients, with frequency of follow-up based on findings. Offering germline testing for offspring should be considered.

Original languageEnglish
Pages (from-to)932-941
Number of pages10
JournalGastroenterology
Volume170
Issue number5
DOIs
Publication statusE-pub ahead of print - 9 Mar 2026

Bibliographical note

Publisher Copyright:
© 2026 The Author(s). Published by Elsevier Inc. on behalf of the AGA Institute. This is an open access article under the CC BY license. http://creativecommons.org/licenses/by/4.0/

Fingerprint

Dive into the research topics of 'Prevalence and Consequences of APC Mosaicism in Patients With Colorectal Adenomas'. Together they form a unique fingerprint.

Cite this